Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma
3 Ansichten
administrator
07/18/23
Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.
Zeig mehr
Facebook Kommentare
Keine Kommentare gefunden